Chargement en cours...
Efficacy and Safety of Fingolimod in an Unselected Patient Population
BACKGROUND: Fingolimod is a first in class oral compound approved for the treatment of relapsing-remitting multiple sclerosis (RR-MS). The aim of this study was to evaluate clinical and neuroradiological responses to fingolimod as well as the safety and tolerability in RR-MS patients in clinical pra...
Enregistré dans:
| Publié dans: | PLoS One |
|---|---|
| Auteurs principaux: | , , , , , , , , |
| Format: | Artigo |
| Langue: | Inglês |
| Publié: |
Public Library of Science
2016
|
| Sujets: | |
| Accès en ligne: | https://ncbi.nlm.nih.gov/pmc/articles/PMC4703383/ https://ncbi.nlm.nih.gov/pubmed/26734938 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1371/journal.pone.0146190 |
| Tags: |
Ajouter un tag
Pas de tags, Soyez le premier à ajouter un tag!
|